Copyright Reports & Markets. All rights reserved.

Global Tumor Blood Testing Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Tumor Blood Testing Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Tumor Blood Testing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Blood Protein Testing
    • 1.4.3 Tumor Marker Testing
    • 1.4.4 Others
  • 1.5 Market by Application
    • 1.5.1 Global Tumor Blood Testing Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Ambulatory Surgical Centers
  • 1.6 Coronavirus Disease 2019 (Covid-19): Tumor Blood Testing Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Tumor Blood Testing Industry
      • 1.6.1.1 Tumor Blood Testing Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Tumor Blood Testing Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Tumor Blood Testing Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Tumor Blood Testing Market Perspective (2015-2026)
  • 2.2 Tumor Blood Testing Growth Trends by Regions
    • 2.2.1 Tumor Blood Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Tumor Blood Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Tumor Blood Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Tumor Blood Testing Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Tumor Blood Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Tumor Blood Testing Players by Market Size
    • 3.1.1 Global Top Tumor Blood Testing Players by Revenue (2015-2020)
    • 3.1.2 Global Tumor Blood Testing Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Tumor Blood Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Tumor Blood Testing Market Concentration Ratio
    • 3.2.1 Global Tumor Blood Testing Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Tumor Blood Testing Revenue in 2019
  • 3.3 Tumor Blood Testing Key Players Head office and Area Served
  • 3.4 Key Players Tumor Blood Testing Product Solution and Service
  • 3.5 Date of Enter into Tumor Blood Testing Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Tumor Blood Testing Historic Market Size by Type (2015-2020)
  • 4.2 Global Tumor Blood Testing Forecasted Market Size by Type (2021-2026)

5 Tumor Blood Testing Breakdown Data by Application (2015-2026)

  • 5.1 Global Tumor Blood Testing Market Size by Application (2015-2020)
  • 5.2 Global Tumor Blood Testing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Tumor Blood Testing Market Size (2015-2020)
  • 6.2 Tumor Blood Testing Key Players in North America (2019-2020)
  • 6.3 North America Tumor Blood Testing Market Size by Type (2015-2020)
  • 6.4 North America Tumor Blood Testing Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Tumor Blood Testing Market Size (2015-2020)
  • 7.2 Tumor Blood Testing Key Players in Europe (2019-2020)
  • 7.3 Europe Tumor Blood Testing Market Size by Type (2015-2020)
  • 7.4 Europe Tumor Blood Testing Market Size by Application (2015-2020)

8 China

  • 8.1 China Tumor Blood Testing Market Size (2015-2020)
  • 8.2 Tumor Blood Testing Key Players in China (2019-2020)
  • 8.3 China Tumor Blood Testing Market Size by Type (2015-2020)
  • 8.4 China Tumor Blood Testing Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Tumor Blood Testing Market Size (2015-2020)
  • 9.2 Tumor Blood Testing Key Players in Japan (2019-2020)
  • 9.3 Japan Tumor Blood Testing Market Size by Type (2015-2020)
  • 9.4 Japan Tumor Blood Testing Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Tumor Blood Testing Market Size (2015-2020)
  • 10.2 Tumor Blood Testing Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Tumor Blood Testing Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Tumor Blood Testing Market Size by Application (2015-2020)

11 India

  • 11.1 India Tumor Blood Testing Market Size (2015-2020)
  • 11.2 Tumor Blood Testing Key Players in India (2019-2020)
  • 11.3 India Tumor Blood Testing Market Size by Type (2015-2020)
  • 11.4 India Tumor Blood Testing Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Tumor Blood Testing Market Size (2015-2020)
  • 12.2 Tumor Blood Testing Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Tumor Blood Testing Market Size by Type (2015-2020)
  • 12.4 Central & South America Tumor Blood Testing Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Guardant Health
    • 13.1.1 Guardant Health Company Details
    • 13.1.2 Guardant Health Business Overview and Its Total Revenue
    • 13.1.3 Guardant Health Tumor Blood Testing Introduction
    • 13.1.4 Guardant Health Revenue in Tumor Blood Testing Business (2015-2020))
    • 13.1.5 Guardant Health Recent Development
  • 13.2 Trovagene
    • 13.2.1 Trovagene Company Details
    • 13.2.2 Trovagene Business Overview and Its Total Revenue
    • 13.2.3 Trovagene Tumor Blood Testing Introduction
    • 13.2.4 Trovagene Revenue in Tumor Blood Testing Business (2015-2020)
    • 13.2.5 Trovagene Recent Development
  • 13.3 Genomic Health
    • 13.3.1 Genomic Health Company Details
    • 13.3.2 Genomic Health Business Overview and Its Total Revenue
    • 13.3.3 Genomic Health Tumor Blood Testing Introduction
    • 13.3.4 Genomic Health Revenue in Tumor Blood Testing Business (2015-2020)
    • 13.3.5 Genomic Health Recent Development
  • 13.4 Roche
    • 13.4.1 Roche Company Details
    • 13.4.2 Roche Business Overview and Its Total Revenue
    • 13.4.3 Roche Tumor Blood Testing Introduction
    • 13.4.4 Roche Revenue in Tumor Blood Testing Business (2015-2020)
    • 13.4.5 Roche Recent Development
  • 13.5 Bio-Techne
    • 13.5.1 Bio-Techne Company Details
    • 13.5.2 Bio-Techne Business Overview and Its Total Revenue
    • 13.5.3 Bio-Techne Tumor Blood Testing Introduction
    • 13.5.4 Bio-Techne Revenue in Tumor Blood Testing Business (2015-2020)
    • 13.5.5 Bio-Techne Recent Development
  • 13.6 Pathway Genomics
    • 13.6.1 Pathway Genomics Company Details
    • 13.6.2 Pathway Genomics Business Overview and Its Total Revenue
    • 13.6.3 Pathway Genomics Tumor Blood Testing Introduction
    • 13.6.4 Pathway Genomics Revenue in Tumor Blood Testing Business (2015-2020)
    • 13.6.5 Pathway Genomics Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Tumor Blood Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tumor Blood Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Guardant Health
    Trovagene
    Genomic Health
    Roche
    Bio-Techne
    Pathway Genomics
    ...

    Market segment by Type, the product can be split into
    Blood Protein Testing
    Tumor Marker Testing
    Others
    Market segment by Application, split into
    Hospitals
    Clinics
    Ambulatory Surgical Centers

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Tumor Blood Testing status, future forecast, growth opportunity, key market and key players.
    To present the Tumor Blood Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Tumor Blood Testing are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now